Evidence map›Paper›PMID 17699572›Full record

ArticleJournal of virology2007

Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.

Judith N Mandl, Roland R Regoes, David A Garber, Mark B Feinberg

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. A binary trait model reveals the fitness effects of HIV-1 escape from T cell responses.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. CD8Nature microbiology · 2023
    Article
  7. Modeling the immune response to HIV infection.Current opinion in systems biology · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Modeling T cell responses to antigenic challenge.Journal of pharmacokinetics and pharmacodynamics · 2014
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Judith N MandlGraduate Program in population Biology, Ecology, and Evolution, Emory University, 954 Gatewood Road, Atlanta, GA 30329, USA.
Roland R Regoes
David A Garber
Mark B Feinberg
Emory University · US

Funding

Cellular Immune Responses and AIDS PathogenesisR01AI049155 · NIAID · EMORY UNIVERSITY · PI DERDEYN, CYNTHIA · 2001 to 2005
$4.1M
Quantititive models of CD8+ immune memoryR01AI049334 · NIAID · EMORY UNIVERSITY · PI ANTIA, RUSTOM NOSHIR · 2001 to 2011
$1.6M
NIAID NIH HHS R01 AI049155NIAID NIH HHS R01 AI049334
6 · The paper itself

Abstract

Antiviral CD8(+) T cells are thought to play a significant role in limiting the viremia of human and simian immunodeficiency virus (HIV and SIV, respectively) infections. However, it has not been possible to measure the in vivo effectiveness of cytotoxic T cells (CTLs), and hence their contribution to the death rate of CD4(+) T cells is unknown. Here, we estimated the ability of a prototypic antigen-specific CTL response against a well-characterized epitope to recognize and kill infected target cells by monitoring the immunodominant Mamu-A*01-restricted Tat SL8 epitope for escape from Tat-specific CTLs in SIVmac239-infected macaques. Fitting a mathematical model that incorporates the temporal kinetics of specific CTLs to the frequency of Tat SL8 escape mutants during acute SIV infection allowed us to estimate the in vivo killing rate constant per Tat SL8-specific CTL. Using this unique data set, we show that at least during acute SIV infection, certain antiviral CD8(+) T cells can have a significant impact on shortening the longevity of infected CD4(+) T cells and hence on suppressing virus replication. Unfortunately, due to viral escape from immune pressure and a dependency of the effectiveness of antiviral CD8(+) T-cell responses on the availability of sufficient CD4(+) T cells, the impressive early potency of the CTL response may wane in the transition to the chronic stage of the infection.

Indexed as

Amino Acid SequenceAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesEpitopesImmune SystemMacaca mulattaModels, BiologicalModels, StatisticalModels, TheoreticalMolecular Sequence DataMutationSimian Immunodeficiency VirusTime FactorsVirologyEpitopes

Identifiers

PMID17699572
PMCPMC2168796
OpenAlexW1967032172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.